Physician

Aileen L Chen, M.D.

According to 2025 Medicare claims, Aileen Chen, M.D. (NPI: 1194753350) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07733-1512.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 987 traditional Medicare patients, billed 230,886 HCPCS/CPT codes, and received $3,970,565 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,354 prescription claims across 319 beneficiaries totaling $2,666,896 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 33 claims. Open Payments data shows 163 records totaling $2,980. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,597,107 to $3,970,565. Similarly, Part D prescription costs have risen steadily, from $1,399,216 to $2,666,896. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $398 to $416.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	548	227,390	$2,597,107
2016	638	215,400	$3,090,294
2017	737	247,758	$2,798,839
2018	675	225,303	$3,320,117
2019	651	197,482	$3,355,599
2020	621	226,807	$3,810,950
2021	689	243,739	$4,163,946
2022	732	280,045	$4,351,772
2023	794	215,433	$3,627,803
2024	987	230,886	$3,970,565

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	1,434	$1,399,216
2016	220	1,569	$2,459,261
2017	239	1,519	$2,621,297
2018	215	1,279	$1,949,065
2019	210	1,271	$2,755,307
2020	212	1,219	$2,865,713
2021	252	1,407	$3,505,565
2022	257	1,539	$3,804,780
2023	276	1,414	$3,799,830
2024	319	1,354	$2,666,896

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$490
2016	N/R	53	$14,121
2017	N/R	41	$15,092
2018	N/R	93	$10,393
2019	N/R	98	$6,713
2020	N/R	62	$1,304
2021	N/R	N/R	N/R
2022	N/R	15	$533
2023	N/R	33	$6,151
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	212	244	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	640	2,070	$99
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	279	787	$13
36415	Insertion of needle into vein for collection of blood sample	692	2,732	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	686	2,896	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	26	728	$414,988
Verzenio	Abemaciclib	32	896	$396,582
Xtandi	Enzalutamide	28	840	$343,020
Calquence	Acalabrutinib Maleate	16	480	$244,150
Eliquis	Apixaban	102	4,842	$88,408

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	161	$2,980	Adaptive Biotechnologies Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Aileen L. Chen, M.D.?

Tedicare shows public-source Medicare data for Aileen L. Chen, M.D. (NPI 1194753350), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aileen L. Chen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aileen L. Chen, M.D.?

Aileen L. Chen, M.D. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Aileen L. Chen, M.D. have Open Payments data?

Aileen L. Chen, M.D. has 163 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.